Tris is supported by three business units. The branded pharmaceutical business is focused on improving patients’ experiences by offering extended-release formulations for the pediatric market. The generics division develops products that leverage proprietary technologies and R&D capabilities. A host of patented delivery technologies also help transform immediate-release dosage forms into extended-release formulations in liquid and other patient friendly forms with unique attributes.